# Phosphorus 32 in Treating Patients With Glioblastoma Multiforme

> **NCT00004129** · PHASE1 · UNKNOWN · sponsor: **Center for Molecular Medicine** · enrollment: 12 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **RADIATION:** brachytherapy
- **RADIATION:** phosphorus P32

## Key facts

- **NCT ID:** NCT00004129
- **Lead sponsor:** Center for Molecular Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004129, "Phosphorus 32 in Treating Patients With Glioblastoma Multiforme". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00004129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*